{"id":28357,"date":"2021-05-04T21:23:54","date_gmt":"2021-05-05T01:23:54","guid":{"rendered":"https:\/\/www.bu.edu\/research\/?p=28357"},"modified":"2021-05-05T20:01:09","modified_gmt":"2021-05-06T00:01:09","slug":"call-for-proposals-2021-pfizer-cti","status":"publish","type":"post","link":"https:\/\/www.bu.edu\/research\/2021\/05\/04\/call-for-proposals-2021-pfizer-cti\/","title":{"rendered":"Call for Proposals: 2021 Pfizer CTI"},"content":{"rendered":"<p><span>We are pleased to announce a call for proposals for Pfizer\u2019s Centers for Therapeutic Innovation (CTI) program for collaborative development of novel biotherapeutics.<\/span><\/p>\n<p><strong>Deadline:<\/strong> June 28, 2021<\/p>\n<p><strong>Areas of Interest and Targets\/Pathways of Focus:<\/strong><\/p>\n<ol>\n<li><strong>Oncology<\/strong>: Targeting tumor cells, immuno-oncology, and <span>cancer neo-epitopes that could be leveraged in cancer vaccines\u00a0<\/span><\/li>\n<li><strong>Internal Medicine<\/strong>: Obesity\/cachexia, heart failure, diabetic\/chronic kidney disease, and NASG\/T2D<\/li>\n<li><strong>Inflammation &amp; Immunology<\/strong>: Cellular senescence and inflammation resolution mechanisms, tolerance induction mechanisms in autoimmunity, modulating the activity of pathogenic immune cells, and promotion of epithelial barrier repair<\/li>\n<li><strong>Rare disease<\/strong>: Cardiology, metabolic, hematology, and renal diseases<\/li>\n<\/ol>\n<p><strong>Submission Process:\u00a0<\/strong>Submission entails a non-confidential 2-3 page overview of the target, mechanism, evidence for disease linkage, and the proposed therapeutic drug. Pre-proposals should be reviewed by one of Pfizer\u2019s Emerging Science Leads to determine suitability prior to submission, formal submission should be routed through business\/tech-transfer offices.. <span>For further information about submitting a pre-proposal, please contact Nevena Dimova at\u00a0<\/span><a href=\"mailto:ndimova@bu.edu\">ndimova@bu.edu<\/a><span>.<\/span><\/p>\n<p style=\"text-align: center;\"><a href=\"\/research\/files\/2021\/05\/2021-Pfizer-CTI-CFP.pdf\" class=\"button\">Request for Proposals<\/a><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>We are pleased to announce a call for proposals for Pfizer\u2019s Centers for Therapeutic Innovation (CTI) program for collaborative development of novel biotherapeutics. Deadline: June 28, 2021 Areas of Interest and Targets\/Pathways of Focus: Oncology: Targeting tumor cells, immuno-oncology, and cancer neo-epitopes that could be leveraged in cancer vaccines\u00a0 Internal Medicine: Obesity\/cachexia, heart failure, diabetic\/chronic [&hellip;]<\/p>\n","protected":false},"author":17607,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[225,426,247],"tags":[],"_links":{"self":[{"href":"https:\/\/www.bu.edu\/research\/wp-json\/wp\/v2\/posts\/28357"}],"collection":[{"href":"https:\/\/www.bu.edu\/research\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.bu.edu\/research\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.bu.edu\/research\/wp-json\/wp\/v2\/users\/17607"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bu.edu\/research\/wp-json\/wp\/v2\/comments?post=28357"}],"version-history":[{"count":3,"href":"https:\/\/www.bu.edu\/research\/wp-json\/wp\/v2\/posts\/28357\/revisions"}],"predecessor-version":[{"id":28373,"href":"https:\/\/www.bu.edu\/research\/wp-json\/wp\/v2\/posts\/28357\/revisions\/28373"}],"wp:attachment":[{"href":"https:\/\/www.bu.edu\/research\/wp-json\/wp\/v2\/media?parent=28357"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.bu.edu\/research\/wp-json\/wp\/v2\/categories?post=28357"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.bu.edu\/research\/wp-json\/wp\/v2\/tags?post=28357"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}